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Abstract 
Tuberous Sclerosis Complex is a rare genetic disorder inherited in autosomal dominant fashion. Tuberous Sclerosis 
Complex or Bourneville’s disease, first described by Desiree Magloire Bourneville in 1880 has a prevalence of 1 in 
6000 live birth.. It is a multisystem disorder involving brain, skin, kidneys, heart, eyes and lungs which becomes 
apparent only in late childhood, limiting the usefulness in early diagnosis in infancy .Here we report a case of 9 year 
old female child presenting with chief complaints of skin lesions, developmental delay and seizures in Regional 
Hospital, Kullu and diagnosed as Tuberous Sclerosis. 
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Introduction 
 
Case report 
History: A 9 year old female child from a nearby 
village presented in pediatric OPD with multiple skin 
lesions over face and chest present since infancy. 
Parents had taken medications from multiple 
practitioners but skin lesions persisted. She gave 
history of multiple episodes of abnormal body 
movements for past 3 years suggestive of right sided 
focal seizures which had resolved spontaneously for 
past one year without any medication and had one 
episode just before visit. She was born of non 
consanguineous marriage with uneventful birth history. 
There was no history of seizure in family members; 
however his father had skin nodules over the face and 
neck along with a hypopigmented macule over the 
trunk. 
Examination: On detailed examination, the child was 
found to be malnourished (Protein energy malnutrition 
Grade II as per Indian Academy of Paediatrics 
Classification based on weight for age) with Tanner 
stage I of physical development. The child had multiple 
hyper-pigmented papules over the malar region 
(adenoma sebaceum) and forehead.  
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She also had multiple (five) hypo-pigmented macules 
(ash leaf) over the chest and lower limbs along with a 
Shagreen patch over the lateral aspect of the left 
buttock. She had mild mental retardation, rest of 
detailed CNS examination was normal. Systemic 
examination and fundus examination revealed no 
abnormality. 
Investigations: showed sub ependymal nodules in 
computed tomography (CT) scan of head. Blood 
investigations test complete haemogram, serum 
calcium, renal and liver function tests were normal. 
Ultrasound KUB was normal. X-ray of both hands was 
normal. 
Management: Anti epileptic Carbamazapine (15 
mg/kg/day) was started for seizure management and 
currently the child is seizure free for past 6 months on 
medication. 
 
Discussion 
Tuberous sclerosis complex (TSC) is a rare genetic 
disorder with heterogeneous presentation varying from 
severe mental retardation and incapacitating seizures to 
normal intelligence and an absence of seizure, often 
within the same family. It is due to inactivating 
mutation in one of the two genes, TSC1 encoding 
hamartin, or TSC2 encoding tuberin[1,2] .The major 
neurological manifestations of Tuberous Sclerosis 
Complex are seizures, autism, developmental delay and 
behavioral and psychiatric disorder. Seizure is present 
in about 80-90% of patient which begins during the 
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first year of life; varies from subtle focal seizure, 
infantile spasm, to generalized seizure[1,3].. Seizures 
are managed with an anticonvulsant medication like 
Vigabatrin for infantile spasm, Lamotrigine for 
generalized seizure[2]. But young children with TSC 
who have early onset of focal seizure or spasm, 
develops intractable seizures later that responds poorly 
to antiepileptic drug[1] . Those are candidates for 
alternative non-pharmacological treatment which 
includes vagus nerve stimulation, use of ketogenic diet, 
and resective surgery[4].TSC has dermatologic 
manifestations like hypomelanotic macules(90%), 
facial angiofibromas (75%), Shagreen patch (20-
30%)[2] . 
1. Hypomelanotic macules are present at birth and 
almost all lesions are evident within the first two 
years of life. 
2. Facial angiofibromas (adenoma sebaceum) are 
present during preschool years(3-6yrs) in the malar 
area as small pink to red dome-shaped papules in a 
“butterfly distribution”. 
3. The Shagreen patch is found in the lumbosacral 
region characteristically present as an irregularly 
shaped roughened raised lesion with orange peel 
consistency. 
Adolescent pediatric children may have cosmetic 
issues, so recent trial support the use of topical 0.1% 
Rapamycin on facial angiofibromas[5] . Use of 
Inhibitors of the mammalian target of rapamycin 
(mTOR) in regression of astrocytomas, angiofibromas 
and angiomyoliomas are newer modalities in the 
management of tuberous sclerosis[6]. Diagnostic 
Criteria for TSC is as given in the table below. Definite 
TSC can be made when two major or one major plus 
two minor features are demonstrated[7].Our patient had 
four major criteria (subependymal nodules in CT scan 
head, facial angiofibroma, hypomelanotic macules 
more than three in number, Shagreen patch) which fit 
in the diagnosis of Tuberous sclerosis. 
 
Table1:Major and minor symptoms 
 
Major Minor 
Facial angiofibroma Multiple pits in dental enamel 
Ungual fibroma Hamartomatous rectal polyps 
Shagreen patch Bone cysts 
Hypomelanotic macule Cerebral white matter radial migration line 
Cortical tuber Gingivial fibromas 
Subependymalnodule Retinal achromic patch 
Subependymal giant-cell tumour Confetti skin lesions 
Retinal hamartoma Multiple renal cysts 
Cardiac rhabdomyoma  
Renalangiomyolipoma  
Lymphangiomyomatosis  
Our patient had four major criteria (subependymal nodules in CT scan head, facial angiofibroma, hypomelanotic 
macules more than three in number, Shagreen patch) which fit in the diagnosis of Tuberous sclerosis. 
 
Fig 1:Ash leaf macule,shagreen spot,adenoma sebaceum 
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Fig 2:CECT brain showing multiple small subcentimeter sized calcified subependymal nodules along bilateral 
lateral ventricles,bilateral hemispherica cortex and bilateral fronto parietal region 
 
 
Conclusion  
 
TSC is one of the neurocutaneous syndromes inherited 
in autosomal dominant fashion with almost complete 
penetrance with variable expressivity, affecting almost 
all organs. The quality of life depends on the 
neurological manifestation like seizures and mental 
retardation which is improved by multidisciplinary 
approach and symptomatic organ specific treatment. 
Clinical diagnosis complementing with DNA testing 
allows precise genetic counseling, which is important. 
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